Document is current
Any future updates will be listed below
-
Authors
Sherratt-Mayhew, Sam
Page, Charles
Berman, Gabriele
Mollan, Susan P.
- License Information
-
More Information
Article History
Received: 18 June 2025
Revised: 2 July 2025
Accepted: 3 July 2025
First Online: 16 July 2025
Competing interests
: Susan Mollan reports consultancy fees (Invex Therapeutics); advisory board fees (Ocular therapeutix); speaker fees (Teva); Travel (Abbvie and European Alliance of Associations for Rheumatology); Receipt of equipment (Heidelberg Engineering). Susan Mollan is a section editor at Eye Journal. Authors declare no other financial relationships with any organisations that might have an interest in the submitted work; and no other relationships or activities that could appear to have influenced the submitted work.
